SCHEMBL3853330

SCHEMBL3853330

Clc1cnc2[nH]cc(COc3cccc(OCc4ccccc4)c3OCC3CC3)c2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.41
CYP2C19 P33261 2/20 0.41
CYP1A2 P05177 2/20 0.41
MEN1 O00255 1/20 0.41
TP53 P04637 1/20 0.41
CYP2D6 P10635 1/20 0.41
MAPT P10636 1/20 0.41
ALOX15 P16050 1/20 0.41
ADRA1D P25100 1/20 0.41
MAPK1 P28482 1/20 0.41
ADRA1A P35348 1/20 0.41
ADRA1B P35368 1/20 0.41
KMT2A Q03164 1/20 0.41
JAK2 O60674 1/20 0.41
SLC6A4 P31645 2/20 0.40
HTR6 P50406 2/20 0.39
KCNH2 Q12809 2/20 0.39
SNCA P37840 1/20 0.38
CYP2C9 P11712 1/20 0.37
HTR2A P28223 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1050339 0.84 JAK2 (0.37) CYP3A4CYP2C19CYP1A2MEN1TP53
SCHEMBL1050439 0.84 PAK1 (0.42) MEN1KMT2AJAK2
SCHEMBL1053265 0.72 LCK (0.41) CYP3A4CYP2C19ADRA1ASLC6A4KCNH2
SCHEMBL417796 0.71 CYP3A4 (0.46) CYP3A4CYP2C19CYP1A2CYP2D6ADRA1A
SCHEMBL1052531 0.70 CYP2C9 (0.47) CYP3A4CYP2C19CYP1A2CYP2D6MAPT
SCHEMBL1053363 0.70 CYP2C9 (0.41) CYP3A4CYP2C19SNCACYP2C9
SCHEMBL1054824 0.69 CYP2C9 (0.52) CYP3A4CYP2C19CYP1A2CYP2D6MAPT
SCHEMBL1050251 0.68 PAK1 (0.36) CYP2C19CYP2C9
SCHEMBL1053572 0.68 PAK1 (0.41) CYP3A4CYP2C19CYP2C9
SCHEMBL8941196 0.67 JAK2 (0.67) JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2094701-A2 COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR PLEXXIKON, INC. (US) 2009-09-02 EP disclosed
WO-2008080001-A2 COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR PLEXXIKON, INC. (US) 2008-07-03 WO disclosed
WO-2008080015-A2 COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR PLEXXIKON, INC. (US) 2008-07-03 WO disclosed